Application Deadline: 30 Nov 2016
Applications are invited for 15 PhD candidate positions under EU Horizon 2020 Marie Skłodowska-Curie Action COFUND action – BioMEP doctoral programme – which offers unique inter/multidisciplinary and intersectoral research and training opportunities for young scientists in Biomedical Engineering and Medical Physics across Europe.
The BioMEP training and research activities are characterized by a multidisciplinary approach and allows candidates to submit proposals under the following five focus research areas:
More information on the application and evaluation procedure for the BioMEP doctoral positions is available on the BioMEP homepage: http://www.uef.fi/biomep.
The deadline for sending the application is November 30, 2016, at 16:00 CET.
Deadline: 07 Oct 2016
The units of Policy Access and Use and Public Health and innovation of the Essential Medicines and Health products department of WHO are being merged into one new unit which is called “Innovation, Access and Use” .
~ Mark your calendar – October 21, 2016 ~
On behalf of the Global Clinical Engineering Advisory Board, you are invited to participate and engage in a day-long recognition event celebrating the contributions clinical engineers make every day. Health technology is vital to global health care and therefore its optimal management has never been more critical for patient outcomes.
On October 21, 2016, the first Global Clinical Engineering Day will be celebrated around the world. On that day, for 24 hours, the website http://global.icehtmc.com will feature interviews with members of the CE community, highlighting associations function from around the world such as ACCE, chat room in different languages, and streaming videos showing off various CE roles and functions.
You are invited to submit photos and, more important, short videos to be broadcast throughout that day. Rotating around the world in each of the world’s time zones, delegates will be online sharing their experiences and responding to participants’ comments. Short videos of up to 5 minutes are preferred as well other material like brochures, professional success stories and similar content are welcome. Please create a video of your department and send it over so we can show off our accomplishments.
This event is sponsored by an international group supported by the International Federation of Biological and Medical Engineering (IFMBE) Clinical Engineering Division (CED), in collaboration with the World Health Organization (WHO), and national CE associations including those in Italy, Brazil and China.
For more information, please feel free to contact Yadin David, CE Advisory Board Chairman at David@BiomedEng.com.
WHO’s 2014 Compendium of Innovative Health Technologies for Low-Resource Settings is now available for download at:
Dear colleagues of Biomedical Engineering,
The board of the Brazilian Society of Biomedical Engineering (SBEB) is sad to announce that our colleague Professor Antonio Fernando Catelli Infantosi passed away on 16 March 2016.
Prof. Infantosi is one of the biggest names in Biomedical Engineering in Brazil, he was one of the founders of the Biomedical Engineering Program of COPPE-UFRJ, the SBEB and journal Research on Biomedical Engineering (RBE). He was President of SBEB several times and president of the Latin American Regional Council on Biomedical Engineering (CORAL).
The board of the SBEB deeply regrets this loss and sends sincere condolences to Prof. Infantosi’s family, friends and students.
Prof. Sérgio Santos Mühlen, DSc, CCE
President of the Brazilian Society of Biomedical Engineering – SBEB
Our friend and our colleague Prof Robert Brown sadly passed away on 4th February 2016 at the age of 64. An extraordinary human being, Robert is survived by his mother Doris Brown, his daughter Elizabeth Pelichet, his son Michael Brown and grandson Finlay Brown. His passing is a huge loss to the UCL community and the tissue engineering community in the UK, Europe and Internationally. He was as well a key figure of the IFMBE Working Group for Cell and Stem Cell Engineering.
Robert was awarded his Ph.D. in 1976 by Manchester University where, under the supervision of Dr J.B.Weiss, he successfully defended his research into “A Molecular Dissection of Rheumatoid and Normal Synovial Membranes with Special Reference to their Collagen Contents”. This started his lifelong fascination of all things collagen. He had a brief stint with industry working first as a research assistant and then as Deputy Head of R&D with Blood Products Laboratory (Elstree) between 1977-1983 before joining UCL Institute of Orthopaedics and Musculoskeletal Science, Royal National Orthopaedics Hospital, Stanmore as a Lecturer/Senior Lecturer ( 1984-1992). In 1992 on his promotion to Reader he moved his research base to Bloomsbury as Director of the Tissue Repair Unit which he setup along with the UCL Tissue Engineering Centre (TREC). In 2002 he was appointed as UCL’s first Professor of Tissue Engineering and moved his research base back to Institute of Orthopaedics and Musculoskeletal Science, Royal National Orthopaedics Hospital, Stanmore. He was a founding member of the British Tissue Engineering community and past president of the Tissue and Cell Engineering Society (TCES) UK.
His key research achievements were in understanding the control of growth, especially nano-micro struc-ture, in 3D tissue models. 2 key output innovations underpinned this: orientated fibrillar fibronectin cell scaffolds and the Culture Force Monitor (CFM) model, measuring/applying directional loads to 3D culture. He was a pioneer in developing 3D models and their use in elucidating the effect of mecha-nics. His research innovation (Plastic Compression -rapid, biomimetic fabrication process for collagen tissues) established him as an international leading scientist for biomimetic tissue engineering. His ability to collaborate across disciplines resulted in many successful research alliances with leading scientists in the UK, Europe and Internationally. He successfully supervised over 30 M.D. and Ph.D. students, over 60 M.Sc. projects and numerous post-doc researchers. Throughout his career at UCL Robert was a beloved teacher, a sought after research supervisor, collaborator and friend to many UCL colleagues across Faculties. He was also a very popular and highly regarded scientist in the Tissue Engineering community nationally and internationally.
Robert leaves behind a rich legacy of scientific innovations, motivated students with successful careers and scientifically productive collaborations across the UK, Europe and Internationally. But most importantly he leaves behind a legacy of global friendships brought together by Robert’s passion for science and human beeings. We feel honoured to have spent time with a distinguished scientist, a funny storyteller and remarkable man. Rest in peace our dear Robert.
Chair IFMBE Working Group, Cell and Stem Cell Engineering,
February 11th, 2016
The German Society for Biomedical Engineering at the VDE Association is awarding the literature prize to young scientist from the “Klee Family Foundation”. The prize is worth 5,000 euros prize and will be awarded in a competition for outstanding scientific work with the following priorities:
The submitted scientific work may be present as a publication in a scientific journal, a dissertation or a book.
Application Deadline: 31st January 2016.
For more details, please visit www.vde.com/klee-preis
The Engineering Medical Innovation Global Competition (EMedic Global) is a global competition for clinically-driven and client-centered engineering innovations in medicine. EMedic Global is dedicated to education and competition, advancement of biomedical engineering, and the development of international exchange.
Submissions will be open to university students around the world. Each submission would be in the form of a short video presentation plus a summary poster. The best 12-15 teams will be selected as the EMedic Global finalists. Finalist teams will be invited to Hong Kong for the on-site final competition and award presentations. CUHK will provide accommodation to all the finalists (up to 4 students plus one faculty advisor per team).
The scope of competition includes:
Read more >> Visit website
The Health Technology Assessment Division (HTAD) of the IFMBE is pleased to announce the First IFMBE Summer School on Health Technology Assessment (HTA) for Biomedical Engineers and Medical Physicists: http://www2.warwick.ac.uk/fac/sci/eng/research/systems/abspie/hta/
This Summer School will run the 8th, 9th and 10th of September 2015 in the University of Warwick and speaks directly to PhD Students, Researchers and Academics with a technical background, who are working on healthcare technologies.
The School aims to provide them with theoretical and practical multidisciplinary training on HTA. This will include methodology, modelling, mathematics, laboratory based training and relevant case studies (i.e. medical devices and not only drugs). Attenders will learn principles, methods and how to use tools that will be important to inform their activities, maximising the uptake and impact of their research outcomes. In fact, informing the research and the design of new healthcare technologies with scientific methods for early stage HTA will have a considerable impact on a number of important elements (i.e. cost-effectiveness, ethical issues) during the research process, when with small changes it is possible to achieved big results.
Up to 10 scholarship will be offered to cover the School costs. All the info are available on the web page.
The School has been organized and supported by:
Moreover, the school has been endorsed by:
If you have any question do not hesitate to contact Dr Leandro Pecchia, Chairman of the IFMBE HTA Division and Director of the School (firstname.lastname@example.org)